Table 1.
Disposition of Patients Randomly Assigned to Aripiprazole or Placebo
| Outcome | Placebo (N = 368) | Aripiprazole (N = 373)a |
| Discontinued, N(%) | 46(12.5) | 51(13.7) |
| Lack of efficacy | 5(1.4) | 6(1.6) |
| Adverse event | 6(1.6) | 13(3.5) |
| Subject withdrew consent | 14 (3.8) | 8(2.1) |
| Lost to follow-up | 11(3.0) | 10(2.7) |
| Otherb | 10 (2.7) | 14 (3.8) |
| Completed randomization phase, N (%) | 322(87.5) | 322(86.3) |
a
Two patients who discontinued during the prospective phase were randomly assigned in error and are not included in this table.
b
Includes poor/no compliance, subject no longer meets study criteria, and other known cause.